Skip to main content
Clinical Trials/NCT05489978
NCT05489978
Completed
Not Applicable

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Kathmandu University School of Medical Sciences1 site in 1 country310 target enrollmentJune 15, 2022

Overview

Phase
Not Applicable
Intervention
"Cervical Cancer Stigma Reduction Intervention"
Conditions
Cervical Cancer
Sponsor
Kathmandu University School of Medical Sciences
Enrollment
310
Locations
1
Primary Endpoint
Mean stigma score
Status
Completed
Last Updated
17 days ago

Overview

Brief Summary

It is an interventional study to assess the effectiveness of the cervical cancer stigma reduction intervention on cancer stigma score and cervical cancer screening uptake in Nepal

Detailed Description

Despite the presence of ample evidence, that stigma is one of the major reasons for low screening coverage, Nepal does not have a single stigma reduction intervention targeted among women to increase cervical cancer screening coverage. Therefore, we aim to assess the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will conduct an interventional study in Budanilkhantha Municipality. A computer-based program will randomly allocate the 12 wards of Budanilkhantha Municipality with an allocation ratio 1:1; 6 wards in intervention group and 6 wards in control group. We will conduct a "stigma reduction education program" in the intervention group. After that we will follow up the participants for 2 months to see the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will analyze data using STATA 14. We will use independent tests to find the mean difference between cervical cancer screening uptake and cervical cancer stigma score. The difference in mean among the two groups will actually be the difference due to intervention given. Findings from this study will help managers and stakeholders to formulate and improve strategies on screening programs and develop programs to reduce stigma on cervical cancer among women in Nepal.

Registry
clinicaltrials.gov
Start Date
June 15, 2022
End Date
February 15, 2023
Last Updated
17 days ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Priyanka Timsina

Student

Kathmandu University School of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Women aged 30-60 years (the age range recommended for VIA screening in Nepal
  • Married women
  • Residents of Budanilkantha Municipality

Exclusion Criteria

  • Women who have already undergone screening within 5 years.
  • Women with hearing or mental disorders
  • Pregnant women
  • Less than 6 weeks postpartum
  • Mothers who had lived in the community for less than 6 months to perform seasonal work (e.g. in brick kilns) or visitors in the family.
  • Women who are already diagnosed with cervical pre-cancer and cancer and have undergone hysterectomy.

Arms & Interventions

Intervention Arm

Randomization will allocate women to intervention and control arm in 1:1 ratio; with 6 wards in each group. The intervention arm will consist of 153 women who will receive "Cervical Cancer Stigma Reduction Intervention".

Intervention: "Cervical Cancer Stigma Reduction Intervention"

Control Arm

The control arm will consist of 153 women who would not be given any intervention.

Outcomes

Primary Outcomes

Mean stigma score

Time Frame: Measured at baseline and endline (after 2 months gap from baseline)

Change in mean stigma score using Cancer Stigma Scale at baseline and follow up

Secondary Outcomes

  • Cervical cancer screening uptake(Measured within a month after endline)

Study Sites (1)

Loading locations...

Similar Trials